Overexpression and activation of IDO1 in tumor and antigen-presenting cells can produce toxic tryptophan metabolites and play an important role in tumor-induced immune system tolerance and inhibition, which has become a new important therapeutic target [102,103,104]. This evidence concerns the gene IDO1 and neoplasm.